Sarcos Technology and Robotics Corporation (STRCW)

Sarcos Technology and Robotics Corporation (STRCW) Technology Profile & Competitive Position

Sarcos Technology and Robotics Corporation develops and produces advanced robotic systems, including exoskeletons and tele-operated robots, serving diverse sectors like defense, healthcare, and entertainment. The company differentiates itself through its focus on human-augmentation robotics and Robot-as-a-Service offerings, positioning it within the expanding robotics market.

What Is the Investment Thesis for STRCW?

Sarcos Technology and Robotics Corporation presents a compelling, albeit high-risk, investment opportunity within the robotics sector. The company's focus on human-augmentation robotics, particularly its Guardian XO exoskeleton, addresses a growing need for enhanced worker capabilities in industries such as construction, manufacturing, and logistics. The company's Robot-as-a-Service (RaaS) model for the Guardian S provides recurring revenue streams. With a gross margin of 48.7%, STRCW has demonstrated an ability to generate profits from its sales. However, the company's relatively small size (70 employees) and limited market capitalization ($0.00B) indicate a high degree of volatility. The company's high P/E ratio of 28.00 suggests that the stock may be overvalued relative to its earnings. Investors should carefully consider these factors and conduct thorough due diligence before investing.

Based on FMP financials and quantitative analysis

STRCW Key Highlights

• Gross Margin of 48.7% indicates strong pricing power and efficient cost management in their robotics offerings.
• Profit Margin of 191.4% suggests substantial profitability, although this may be influenced by specific accounting factors or one-time events.
• Beta of 3.25 indicates high volatility relative to the market, suggesting a higher risk profile for investors.
• Market Cap of $1.29M reflects the company's small size and potential for high growth or significant risk.
• The company's focus on Robot-as-a-Service (RaaS) model for some products provides recurring revenue streams.

Who Are STRCW's Competitors?

STRCW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are STRCW's Key Strengths?

• Proprietary exoskeleton technology.
• Strong relationships with defense organizations.
• Recurring revenue from Robot-as-a-Service model.
• Experienced leadership team.

What Are STRCW's Weaknesses?

• Limited market capitalization.
• Reliance on a few key customers.
• High operating expenses.
• Limited brand recognition.

What Could Drive STRCW Stock Higher?

• Continued expansion of Robot-as-a-Service (RaaS) offerings to new customers and industries.
• Commercialization and market launch of the Guardian XO exoskeleton.
• Securing additional contracts with the U.S. Department of Defense and other defense organizations.
• Development of new robotic solutions for healthcare and other sectors.
• Strategic partnerships and acquisitions to expand product portfolio and market reach.

What Are the Key Risks for STRCW?

• Financial-distress signal — its Altman Z-Score of -7.96 sits in the distress zone (elevated bankruptcy risk).
• Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
• Intense competition from larger, more established robotics companies.
• Rapid technological advancements that could render existing products obsolete.
• Economic downturns that could reduce demand for robotic solutions.
• Regulatory changes that could impact the development and deployment of robotic systems.
• Reliance on a few key customers, which could create vulnerability if those relationships are disrupted.

What Are the Growth Opportunities for STRCW?

• Expansion of Robot-as-a-Service (RaaS) Offerings: Sarcos can expand its RaaS model beyond the Guardian S to other products like the Guardian GT and XO. The RaaS model provides recurring revenue streams and reduces upfront costs for customers, making the technology more accessible. The market for RaaS is projected to grow significantly, driven by the increasing adoption of automation across various industries. Timeline: Ongoing.
• Penetration of the Defense Sector: Sarcos has a strong heritage in defense applications, stemming from its origins as a Raytheon subsidiary. The company can leverage this expertise to secure additional contracts with the U.S. Department of Defense and other international defense organizations. The defense robotics market is substantial, driven by the need for enhanced capabilities in surveillance, reconnaissance, and explosive ordnance disposal. Timeline: Ongoing.
• Commercialization of the Guardian XO Exoskeleton: The Guardian XO exoskeleton has the potential to revolutionize industries such as construction, manufacturing, and logistics by enhancing worker strength and endurance. Sarcos can focus on commercializing the Guardian XO through strategic partnerships with companies in these sectors. The market for exoskeletons is projected to grow rapidly, driven by the aging workforce and the increasing demand for improved worker safety and productivity. Timeline: Upcoming: within the next 1-2 years.
• Development of New Robotic Solutions for Healthcare: Sarcos can leverage its expertise in robotics to develop new solutions for the healthcare industry, such as surgical robots, rehabilitation robots, and assistive devices for the elderly. The healthcare robotics market is growing rapidly, driven by the aging population and the increasing demand for minimally invasive procedures. Timeline: Ongoing.
• Strategic Partnerships and Acquisitions: Sarcos can pursue strategic partnerships and acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. Potential targets include companies specializing in sensors, artificial intelligence, and other related fields. This could accelerate the company's growth and enhance its competitive position. Timeline: Ongoing.

What Opportunities Does STRCW Have?

• Expansion into new markets and industries.
• Development of new robotic solutions for healthcare and other sectors.
• Strategic partnerships and acquisitions.
• Increased adoption of automation across various industries.

What Threats Does STRCW Face?

• Intense competition from larger robotics companies.
• Rapid technological advancements.
• Economic downturns.
• Regulatory changes.

What Are STRCW's Competitive Advantages?

• Proprietary technology in human-augmentation robotics, particularly exoskeleton technology.
• Strong heritage in defense applications and relationships with government agencies.
• Robot-as-a-Service (RaaS) model providing recurring revenue streams.
• Expertise in tele-operation and sensor technology.

What Does STRCW Do?

Sarcos Technology and Robotics Corporation, founded in 1983 and headquartered in Salt Lake City, Utah, with an additional office in Bellevue, Washington, specializes in the design, development, and production of advanced robotic systems and sensors. Originally a subsidiary of Raytheon Company, Sarcos has evolved into a key player in the robotics industry, offering a range of products aimed at enhancing human capabilities and improving operational efficiency across various sectors. The company's product portfolio includes the Guardian S, an unmanned ground vehicle used for security, inspection, and non-destructive testing, available through a Robot-as-a-Service model. The Guardian GT is a dual-armed, human-controlled robot mounted on a tracked vehicle designed for commercial, industrial, and first responder applications. The Guardian XO is a full-body exoskeleton suit designed to enhance strength and endurance. The SenSuit controller garment enhances the teleoperation of the Guardian XT, a highly dexterous mobile robotic system. Sarcos also develops humanoid solutions and advanced robotic systems for industry, entertainment, and medical devices, including artificial limbs and vascular systems, as well as mechanical and electrical microsystems. The company serves a diverse range of industries, including healthcare, life sciences, telecommunications, robotics, defense, and entertainment.

What Products and Services Does STRCW Offer?

• Designs and builds dexterous tele-operated robotic systems.
• Produces unmanned ground vehicles for security and inspection.
• Develops dual-armed, human-controlled robots for industrial applications.
• Creates full-body exoskeleton suits to enhance human strength and endurance.
• Offers controller garments for enhanced teleoperation of robotic systems.
• Provides advanced robotic systems for industry, entertainment, and medical devices.
• Develops mechanical and electrical microsystems for practical applications.

How Does STRCW Make Money?

• Sells robotic systems and related hardware.
• Offers Robot-as-a-Service (RaaS) subscriptions for certain products.
• Provides maintenance and support services for its robotic systems.
• Generates revenue through contracts with government agencies and commercial customers.

What Industry Does STRCW Operate In?

Sarcos Technology and Robotics Corporation operates within the rapidly expanding robotics industry, which is driven by increasing automation across various sectors, including manufacturing, logistics, healthcare, and defense. The market is characterized by intense competition and rapid technological advancements. Sarcos differentiates itself through its focus on human-augmentation robotics, particularly its exoskeleton technology. Competitors include companies like AEYGQ (Unknown), CYRNQ (Unknown), MCLD (Unknown), MYNA (Unknown), and NIR (Unknown), each with their own specializations within the broader robotics landscape. The global robotics market is projected to reach hundreds of billions of dollars in the coming years, presenting significant growth opportunities for companies like Sarcos.

Who Are STRCW's Key Customers?

• Defense organizations requiring advanced robotic solutions.
• Industrial companies seeking to improve efficiency and safety.
• Healthcare providers looking for robotic-assisted surgery and rehabilitation tools.
• Entertainment companies utilizing robotics for special effects and attractions.

F-Score 1/9Financial Health

Sarcos Technology and Robotics Corporation's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.96 places it in the distress zone, a signal of elevated financial risk.

STRCW Financials

STRCW Latest News

No recent news available for STRCW.

STRCW Analyst Consensus

STRCW MoonshotScore

What Investors Ask About Sarcos Technology and Robotics Corporation (STRCW) — Technology

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources